ADALIMUMAB THERAPY FOR REFRACTORY BIRDSHOT CHORIORETINOPATHY

Purpose:To report the outcome of using adalimumab to treat birdshot chorioretinopathy.Methods:Retrospective case series of 19 patients (38 eyes) with HLA-A29–positive birdshot chorioretinopathy who received adalimumab treatment. Patients had been refractory to previous standard systemic immunomodula